Table 2.

ADCs in clinical development

ADCs in clinical development

HL indicates Hodgkin lymphoma; ALCL, anaplastic large-cell lymphoma; NHL, non-Hodgkin lymphoma; ALL, acute lymphocytic leukemia; MBC, metastatic breast cancer; DLBCL, diffuse large B-cell lymphoma; RCC, renal cell carcinoma; CLL, chronic lymphocytic leukemia; and SCLC, small-cell lung cancer.

Close Modal

or Create an Account

Close Modal
Close Modal